Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Molecular Pharmacology|October 7, 2004
Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7Changlu Liu, Jingcai Chen, Chester Kuei, et al.The Journal of Biological Chemistry|October 3, 2003
Identification of relaxin-3/INSL7 as a ligand for GPCR142Changlu Liu, Jingcai Chen, Steven Sutton, et al.Molecular Pharmacology|March 18, 2005
Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1Jingcai Chen, Chester Kuei, Steven Sutton, et al.European Journal of Pharmacology|June 28, 2008
Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135)Jessica Zhu, Chester Kuei, Steven Sutton, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2017
Sexual and Gender Minority Issues Across NCCN Guidelines: Results From a National SurveyJanella Hudson, Matthew B Schabath, Julian Sanchez, et al.The Journal of Biological Chemistry|October 3, 2003
Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135Changlu Liu, Elo Eriste, Steven Sutton, et al.British Journal of Pharmacology|February 28, 2006
Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanismsLeon Chang, Lin Luo, James A Palmer, et al.Annals of the New York Academy of Sciences|May 7, 2009
Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7Changlu Liu, Chester Kuei, Steven Sutton, et al.Contemporary Clinical Trials|October 24, 2025
Rationale and study protocol for a pilot study to determine the feasibility and acceptability of a tailored stress management enhanced behavioral weight loss intervention for Black breast cancer survivors with obesityTiffany L Carson, Adana A M Llanos, Khaliah Fleming, et al.Bone Marrow Transplantation|March 9, 2018
Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: a secondary data analysis from the BMT CTN 0902 trialHeather S L Jim, Steven Sutton, Navneet S Majhail, et al.Pageof 2